CREDIT AGREEMENT dated as of August 18, 2017 among INNOVIVA, INC., as the Borrower, The Several Lenders from Time to Time Parties Hereto and MORGAN STANLEY SENIOR FUNDING, INC., as Administrative Agent and Collateral Agent MORGAN STANLEY SENIOR...Credit Agreement • August 21st, 2017 • Innoviva, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 21st, 2017 Company Industry JurisdictionCREDIT AGREEMENT dated as of August 18, 2017 among INNOVIVA, INC., a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement as “Lenders,” and MORGAN STANLEY SENIOR FUNDING, INC. (“MSSF”), as administrative agent (in such capacity, and together with its successors and assigns in such capacity, the “Administrative Agent”) and as collateral agent (in such capacity, and together with its successors and assigns in such capacity, the “Collateral Agent”).
ASSIGNMENT AGREEMENT Dated: August 18, 2017Assignment Agreement • August 21st, 2017 • Innoviva, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 21st, 2017 Company IndustryPursuant to Sections 11.1(a) and 11.2 of the Amended and Restated Indenture, dated as of August 3, 2016 (the “Amended and Restated Indenture”), by and between LABA Royalty Sub LLC, a Delaware limited liability company (the “Issuer”) and U.S. Bank National Association, as initial trustee (in such capacity, the “Trustee”), the Amended and Restated Indenture has been satisfied and released, and the Security Interest granted to the Trustee in the Collateral has been terminated and any funds on deposit in the Collection Account and all other Collateral have been released to the Issuer (the “Release of Collateral”). Capitalized terms used but not defined herein shall have the meanings given them in the Amended and Restated Indenture.
TERMINATION AGREEMENTTermination Agreement • August 21st, 2017 • Innoviva, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 21st, 2017 Company IndustryTERMINATION AGREEMENT (this “Agreement”), dated as of August 18, 2017, by and among LABA ROYALTY SUB LLC, a Delaware limited liability company (the “Issuer”), INNOVIVA, INC., a Delaware corporation previously known as Theravance, Inc. (“Innoviva”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association (“U.S. Bank”).